In an unassuming building in the Nelson suburb of Stoke, pioneering medical research is under way. The latest, for a Pfizer flu vaccine that – if proven effective – could become the first influenza vaccine on the market using mRNA, the technology in the Pfizer and Moderna Covid-19 vaccines. About 46,000 people worldwide were taking part in the clinical trial of the Pfizer flu vaccine, now in its third and final phase, the co-owners of the Southern Clinical Trials Tasman site on Main Road Stoke, GP Claire Thurlow and husband Tristan Riley said. The clinic was looking for more people in that age group to take part in the research, who had not yet had their flu shot this year. Influenza – or flu – was estimated to kill about 500 people a year in New Zealand.

Source: Stuff May 17, 2023 06:01 UTC